<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="[OANC]/data/written_2/technical/biomed/bcr571.anc" start="8870" end="8875" sStart="8784" offset="86" sid="null" wn="1" wnkey="use%2:34:01::" annotator="veweser" text="Radiation hybrid mapping was used to localize the MADS on human chromosomes using high-resolution Gene-Bridge 4 radiation hybrid panels (Research Genetics, Inc, Carlsbad, CA, USA)." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr571.anc" start="8870" end="8875" sStart="null" offset="86" sid="null" wn="1" wnkey="use%2:34:01::" annotator="jeneale" text="Radiation hybrid mapping was used to localize the MADS on human chromosomes using high-resolution Gene-Bridge 4 radiation hybrid panels (Research Genetics, Inc, Carlsbad, CA, USA)." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr571.anc" start="8870" end="8875" sStart="null" offset="86" sid="null" wn="1" wnkey="use%2:34:01::" annotator="cgozo" text="Radiation hybrid mapping was used to localize the MADS on human chromosomes using high-resolution Gene-Bridge 4 radiation hybrid panels (Research Genetics, Inc, Carlsbad, CA, USA)." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr571.anc" start="8870" end="8875" sStart="null" offset="86" sid="null" wn="1" wnkey="use%2:34:01::" annotator="brubin" text="Radiation hybrid mapping was used to localize the MADS on human chromosomes using high-resolution Gene-Bridge 4 radiation hybrid panels (Research Genetics, Inc, Carlsbad, CA, USA)." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr571.anc" start="15930" end="15934" sStart="null" offset="86" sid="r7.1.use.v.0155" wn="1" wnkey="use%2:34:01::" annotator="brubin" text="The Spectrum Green labeled centromere of chromosome 8 (Vysis) was used as a control." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr571.anc" start="2577" end="2587" sStart="null" offset="3" sid="r10.particular.j.0437" wn="2147483647" wnkey="null" annotator="veweser" text="In particular, mutations of genes regulating cell adhesion molecules have been reported to be metastasis-fostering alterations [ 5 6 7 8 ] . In human breast cancers, several other genes have been found to be associated with metastasis, namely nm23 [ 9 10 ] , KAI1 [ 11 12 ] , mta1 [ 13 ] , KiSS1 [ 14 ] , PTEN/MMAC1 [ 15 16 ] and BRMS1 [ 17 ] ." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr571.anc" start="1778" end="1784" sStart="null" offset="224" sid="r8.number.n.0912" wn="1" wnkey="number%1:07:00::" annotator="cgozo" text="It is probable, however, that like tumorigenicity suppressor genes and oncogenes many more genes involved in metastasis remain to be discovered since the process is complex, involving a large number of pathways [ 4 ] . Most of the known genetic mechanisms involved in the progression of a tumor to the metastatic state involve the loss of function of genes that prevent cells from becoming invasive." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr571.anc" start="8445" end="8451" sStart="null" offset="46" sid="null" wn="1" wnkey="normal%3:00:01::" annotator="veweser" text="Positive clones (showing signals in normal cell DNA and missing in metastatic cell DNA) were sequenced." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr571.anc" start="7596" end="7602" sStart="null" offset="97" sid="null" wn="1" wnkey="normal%3:00:01::" annotator="veweser" text="The metastatic cancer cell DNA was used as the 'driver' and the DNA from the normal cells was the 'tester'." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr571.anc" start="12045" end="12051" sStart="null" offset="89" sid="r9.normal.j.0725" wn="1" wnkey="normal%3:00:01::" annotator="veweser" text="These 100 clones were probed (labeled with ? 32P-dCTP) on dot blots containing normal cell DNA and metastatic cell DNA." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr571.anc" start="11442" end="11448" sStart="null" offset="252" sid="r9.normal.j.0365" wn="1" wnkey="normal%3:00:01::" annotator="veweser" text="Since the objective was to isolate sequences that are lost in the progression of cells from normal to metastasis, we focused on the products of RDA in which the metastatic cell DNA was used as the driver and the normal cell DNA was the tester." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr571.anc" start="3401" end="3407" sStart="null" offset="38" sid="r9.normal.j.0193" wn="1" wnkey="normal%3:00:01::" annotator="veweser" text="With the RDA method, DNA from normal cells was compared with that of the metastatic cells of the same patient." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr571.anc" start="12305" end="12311" sStart="null" offset="42" sid="r9.normal.j.0064" wn="1" wnkey="normal%3:00:01::" annotator="veweser" text="The remaining clones hybridized with both normal cell DNA and the metastatic cell DNA." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr571.anc" start="8445" end="8451" sStart="null" offset="46" sid="null" wn="1" wnkey="normal%3:00:01::" annotator="sophiavv" text="Positive clones (showing signals in normal cell DNA and missing in metastatic cell DNA) were sequenced." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr571.anc" start="7596" end="7602" sStart="null" offset="97" sid="null" wn="1" wnkey="normal%3:00:01::" annotator="sophiavv" text="The metastatic cancer cell DNA was used as the 'driver' and the DNA from the normal cells was the 'tester'." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr571.anc" start="8445" end="8451" sStart="null" offset="46" sid="null" wn="3" wnkey="normal%3:00:03::" annotator="cgozo" text="Positive clones (showing signals in normal cell DNA and missing in metastatic cell DNA) were sequenced." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr571.anc" start="7596" end="7602" sStart="null" offset="97" sid="null" wn="3" wnkey="normal%3:00:03::" annotator="cgozo" text="The metastatic cancer cell DNA was used as the 'driver' and the DNA from the normal cells was the 'tester'." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr571.anc" start="12305" end="12311" sStart="null" offset="42" sid="r9.normal.j.0064" wn="1" wnkey="normal%3:00:01::" annotator="cgozo" text="The remaining clones hybridized with both normal cell DNA and the metastatic cell DNA." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr571.anc" start="8445" end="8451" sStart="null" offset="46" sid="null" wn="1" wnkey="normal%3:00:01::" annotator="brubin" text="Positive clones (showing signals in normal cell DNA and missing in metastatic cell DNA) were sequenced." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr571.anc" start="7596" end="7602" sStart="null" offset="97" sid="null" wn="1" wnkey="normal%3:00:01::" annotator="brubin" text="The metastatic cancer cell DNA was used as the 'driver' and the DNA from the normal cells was the 'tester'." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr571.anc" start="12305" end="12311" sStart="null" offset="42" sid="r9.normal.j.0064" wn="1" wnkey="normal%3:00:01::" annotator="brubin" text="The remaining clones hybridized with both normal cell DNA and the metastatic cell DNA." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr571.anc" start="8445" end="8451" sStart="null" offset="46" sid="null" wn="1" wnkey="normal%3:00:01::" annotator="anfahmy" text="Positive clones (showing signals in normal cell DNA and missing in metastatic cell DNA) were sequenced." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr571.anc" start="7596" end="7602" sStart="null" offset="97" sid="null" wn="1" wnkey="normal%3:00:01::" annotator="anfahmy" text="The metastatic cancer cell DNA was used as the 'driver' and the DNA from the normal cells was the 'tester'." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr571.anc" start="9556" end="9562" sStart="null" offset="131" sid="r9.normal.j.0714" wn="3" wnkey="normal%3:00:03::" annotator="anfahmy" text="Chromosome preparations were made from phytohemagglutinin-stimulated peripheral blood lymphocyte cultures from normal individuals." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr571.anc" start="12711" end="12717" sStart="null" offset="105" sid="r9.normal.j.0706" wn="2" wnkey="normal%3:00:02::" annotator="anfahmy" text="None of these clones hybridized with the DNA of the metastatic cells, and all were detected in normal cells (Fig." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr571.anc" start="16606" end="16612" sStart="null" offset="178" sid="r9.normal.j.0418" wn="2" wnkey="normal%3:00:02::" annotator="anfahmy" text="First, DNA samples from these five patients were screened by PCR using primers designed for MADS-IX and PTEN . MADS-IX showed PCR amplification in normal cell DNA samples of all the five patients, but the intensities of the PCR bands were less in the primary tumor cell DNA samples and were totally undetectable in the metastatic cell DNA of patients 1 and 3 (Fig." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr571.anc" start="12305" end="12311" sStart="null" offset="42" sid="r9.normal.j.0064" wn="2" wnkey="normal%3:00:02::" annotator="anfahmy" text="The remaining clones hybridized with both normal cell DNA and the metastatic cell DNA." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr571.anc" start="1941" end="1949" sStart="null" offset="387" sid="r11.function.n.0205" wn="3" wnkey="function%1:04:00::" annotator="vebatchelder" text="It is probable, however, that like tumorigenicity suppressor genes and oncogenes many more genes involved in metastasis remain to be discovered since the process is complex, involving a large number of pathways [ 4 ] . Most of the known genetic mechanisms involved in the progression of a tumor to the metastatic state involve the loss of function of genes that prevent cells from becoming invasive." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr571.anc" start="14108" end="14115" sStart="null" offset="215" sid="r10.control.n.0276" wn="4" wnkey="control%1:09:02::" annotator="brubin" text="For this physical mapping, and also to be able to use these sequences to screen additional patient samples, primer pairs were designed for each sequence and tested by PCR on a positive control (human genomic DNA) and on two negative controls (Chinese hamster genomic DNA and no template)." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr571.anc" start="14166" end="14174" sStart="null" offset="273" sid="r10.control.n.0686" wn="4" wnkey="control%1:09:02::" annotator="anfahmy" text="For this physical mapping, and also to be able to use these sequences to screen additional patient samples, primer pairs were designed for each sequence and tested by PCR on a positive control (human genomic DNA) and on two negative controls (Chinese hamster genomic DNA and no template)." />
  </sentences>
</list>